Alzheimer's Disease: Lifecourse Perspectives on Risk Reduction summarizes the growing body of knowledge on the distribution and causes of Alzheimer's disease (AD) in human populations, providing the reader with knowledge on how we define the disease and what its risk and protective factors are in the context of a life-course approach. At the conclusion of the book, the reader will understand why Alzheimer's disease likely begins at conception, then progresses through early-life and adult risk factors that ultimately impact the balance between pathologic insults in the brain and the ability of the brain to modify disease symptoms. In contrast to edited volumes that may have little cohesion, this book focuses on an integrated life-course approach to the epidemiology of dementia, in particular, Alzheimer's disease. * Reviews the current science surrounding Alzheimer's disease* Provides a primer of foundational knowledge on the disease's epidemiology and biostatistics* Utilizes a life-course approach, providing a novel and integrated view of the evolution of this illness from genes to brain reserve* Uses the 'threshold model'-a theory first described by Dr.
Mortimer and widely accepted today-which incorporates the idea of risk factors for the pathology and expression of the disease * Proposes that improving brain health through modifiable behaviors can delay disease onset until a later age* Examines the future of prevention of Alzheimer's disease, a subject of great current interest
Dr. Amy R. Borenstein has been studying Alzheimer's disease for over 30 years, beginning with one of the early case-control studies of this disease. Since 1988, she has been funded by the National Institute on Aging as well as private sources to carry out a wide range of research in different countries and ethnicities focusing on Alzheimer's disease and related dementias. She led a cohort study of 2,000 Japanese Americans living in in King County, Washington (The Kame Project) for 10 years. During the past 15 years, her work has focused on early detection and prevention of Alzheimer's disease. Dr. Borenstein has published extensively in the medical literature and is recognized as a leading epidemiologist in the study of Alzheimer's disease. Dr. James A. Mortimer is a pioneer in the field of Alzheimer's disease and the first scientist to conduct a systematic case-control study of the causes of the disease. He has devoted his professional life to the study of Alzheimer's and Parkinson's disease, and is nationally and internationally recognized as one of the leading researchers in the field of Alzheimer's disease epidemiology. His work in the Nun Study led to the discovery that characteristics of language at age 20 predicted the risk for Alzheimer's 60 years later, suggesting that the origins of the disease date to early life. In 1994, Dr. Mortimer was the Executive Convener of the Fourth International Conference on Alzheimer's Disease. He is the editor of four books, including the Epidemiology of Dementia published in 1981.
Number Of Pages:
- ID: 9780128045381
- Saver Delivery: Yes
- 1st Class Delivery: Yes
- Courier Delivery: Yes
- Store Delivery: Yes
Prices are for internet purchases only. Prices and availability in WHSmith Stores may vary significantly
© Copyright 2013 - 2016 WHSmith and its suppliers.
WHSmith High Street Limited Greenbridge Road, Swindon, Wiltshire, United Kingdom, SN3 3LD, VAT GB238 5548 36